Does the media refer more to HSIC or COO?

In the previous week, Cooper Companies had 6 more articles in the media than Henry Schein. MarketBeat recorded 18 mentions for Cooper Companies and 12 mentions for Henry Schein. Henry Schein's average media sentiment score of 1.32 beat Cooper Companies' score of 1.22 indicating that Henry Schein is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cooper Companies 11 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer HSIC or IDXX?

In the previous week, IDEXX Laboratories had 10 more articles in the media than Henry Schein. MarketBeat recorded 22 mentions for IDEXX Laboratories and 12 mentions for Henry Schein. IDEXX Laboratories' average media sentiment score of 1.43 beat Henry Schein's score of 1.32 indicating that IDEXX Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive IDEXX Laboratories 17 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MMSI or HSIC?

In the previous week, Merit Medical Systems and Merit Medical Systems both had 12 articles in the media. Henry Schein's average media sentiment score of 1.32 beat Merit Medical Systems' score of 0.85 indicating that Henry Schein is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 4 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, PODD or HSIC?

Henry Schein has higher revenue and earnings than Insulet. Henry Schein is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Insulet $2.90B 3.90 $247.10M $4.30 37.97 Henry Schein $13.18B 0.74 $398M $3.31 25.82

Is PODD or HSIC more profitable?

Insulet has a net margin of 10.44% compared to Henry Schein's net margin of 2.95%. Insulet's return on equity of 26.87% beat Henry Schein's return on equity. Company Net Margins Return on Equity Return on Assets Insulet 10.44% 26.87% 12.01% Henry Schein 2.95% 15.44% 5.53%

Does the media refer more to PODD or HSIC?

In the previous week, Insulet had 29 more articles in the media than Henry Schein. MarketBeat recorded 41 mentions for Insulet and 12 mentions for Henry Schein. Henry Schein's average media sentiment score of 1.32 beat Insulet's score of 0.50 indicating that Henry Schein is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Insulet 13 Very Positive mention(s) 1 Positive mention(s) 26 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Henry Schein 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to AMN or HSIC?

In the previous week, Henry Schein had 8 more articles in the media than AMN Healthcare Services. MarketBeat recorded 12 mentions for Henry Schein and 4 mentions for AMN Healthcare Services. Henry Schein's average media sentiment score of 1.32 beat AMN Healthcare Services' score of 0.04 indicating that Henry Schein is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Henry Schein 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Henry Schein (HSIC) Competitors

$85.47 +0.94 (+1.11%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$85.48 +0.00 (+0.01%)

As of 07/24/2026 07:34 PM Eastern

Compare

HSIC vs. COO, IDXX, MMSI, PODD, and AMN

Should you buy Henry Schein stock or one of its competitors? MarketBeat compares Henry Schein with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Henry Schein include Cooper Companies (COO), IDEXX Laboratories (IDXX), Merit Medical Systems (MMSI), Insulet (PODD), and AMN Healthcare Services (AMN). These companies are all part of the "medical" sector.

How does Henry Schein compare to Cooper Companies?

Henry Schein (NASDAQ:HSIC) and Cooper Companies (NASDAQ:COO) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.9% of Henry Schein shares are held by insiders. Comparatively, 2.1% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Henry Schein currently has a consensus price target of $88.62, suggesting a potential upside of 3.68%. Cooper Companies has a consensus price target of $81.85, suggesting a potential upside of 16.41%. Given Cooper Companies' higher possible upside, analysts clearly believe Cooper Companies is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43
Cooper Companies	3 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.38

Cooper Companies has a net margin of 5.57% compared to Henry Schein's net margin of 2.95%. Henry Schein's return on equity of 15.44% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.95%	15.44%	5.53%
Cooper Companies	5.57%	10.88%	7.27%

Henry Schein has higher revenue and earnings than Cooper Companies. Henry Schein is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.74	$398M	$3.31	25.82
Cooper Companies	$4.23B	3.24	$374.90M	$1.18	59.58

Henry Schein has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market.

In the previous week, Cooper Companies had 6 more articles in the media than Henry Schein. MarketBeat recorded 18 mentions for Cooper Companies and 12 mentions for Henry Schein. Henry Schein's average media sentiment score of 1.32 beat Cooper Companies' score of 1.22 indicating that Henry Schein is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Cooper Companies	11 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cooper Companies beats Henry Schein on 9 of the 16 factors compared between the two stocks.

How does Henry Schein compare to IDEXX Laboratories?

Henry Schein (NASDAQ:HSIC) and IDEXX Laboratories (NASDAQ:IDXX) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership and media sentiment.

Henry Schein has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market. Comparatively, IDEXX Laboratories has a beta of 1.55, meaning that its share price is 55% more volatile than the broader market.

In the previous week, IDEXX Laboratories had 10 more articles in the media than Henry Schein. MarketBeat recorded 22 mentions for IDEXX Laboratories and 12 mentions for Henry Schein. IDEXX Laboratories' average media sentiment score of 1.43 beat Henry Schein's score of 1.32 indicating that IDEXX Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
IDEXX Laboratories	17 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Henry Schein presently has a consensus price target of $88.62, indicating a potential upside of 3.68%. IDEXX Laboratories has a consensus price target of $751.00, indicating a potential upside of 37.97%. Given IDEXX Laboratories' stronger consensus rating and higher possible upside, analysts clearly believe IDEXX Laboratories is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by insiders. Comparatively, 0.8% of IDEXX Laboratories shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

IDEXX Laboratories has a net margin of 24.63% compared to Henry Schein's net margin of 2.95%. IDEXX Laboratories' return on equity of 70.87% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.95%	15.44%	5.53%
IDEXX Laboratories	24.63%	70.87%	32.56%

IDEXX Laboratories has lower revenue, but higher earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.74	$398M	$3.31	25.82
IDEXX Laboratories	$4.30B	9.98	$1.06B	$13.58	40.08

Summary

IDEXX Laboratories beats Henry Schein on 12 of the 16 factors compared between the two stocks.

How does Henry Schein compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and Henry Schein (NASDAQ:HSIC) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

Merit Medical Systems currently has a consensus target price of $92.80, indicating a potential upside of 24.87%. Henry Schein has a consensus target price of $88.62, indicating a potential upside of 3.68%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, equities research analysts plainly believe Merit Medical Systems is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43

Henry Schein has higher revenue and earnings than Merit Medical Systems. Henry Schein is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	2.92	$128.49M	$2.31	32.17
Henry Schein	$13.18B	0.74	$398M	$3.31	25.82

In the previous week, Merit Medical Systems and Merit Medical Systems both had 12 articles in the media. Henry Schein's average media sentiment score of 1.32 beat Merit Medical Systems' score of 0.85 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	4 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by insiders. Comparatively, 0.9% of Henry Schein shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Merit Medical Systems has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market.

Merit Medical Systems has a net margin of 9.03% compared to Henry Schein's net margin of 2.95%. Henry Schein's return on equity of 15.44% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.03%	13.54%	7.94%
Henry Schein	2.95%	15.44%	5.53%

Summary

Merit Medical Systems beats Henry Schein on 8 of the 15 factors compared between the two stocks.

How does Henry Schein compare to Insulet?

Insulet (NASDAQ:PODD) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

Insulet has a net margin of 10.44% compared to Henry Schein's net margin of 2.95%. Insulet's return on equity of 26.87% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Insulet	10.44%	26.87%	12.01%
Henry Schein	2.95%	15.44%	5.53%

In the previous week, Insulet had 29 more articles in the media than Henry Schein. MarketBeat recorded 41 mentions for Insulet and 12 mentions for Henry Schein. Henry Schein's average media sentiment score of 1.32 beat Insulet's score of 0.50 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Insulet	13 Very Positive mention(s)	1 Positive mention(s)	26 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Henry Schein	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

96.6% of Henry Schein shares are held by institutional investors. 0.4% of Insulet shares are held by company insiders. Comparatively, 0.9% of Henry Schein shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Henry Schein has higher revenue and earnings than Insulet. Henry Schein is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$2.90B	3.90	$247.10M	$4.30	37.97
Henry Schein	$13.18B	0.74	$398M	$3.31	25.82

Insulet has a beta of 1.11, suggesting that its stock price is 11% more volatile than the broader market. Comparatively, Henry Schein has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

Insulet currently has a consensus price target of $235.25, indicating a potential upside of 44.10%. Henry Schein has a consensus price target of $88.62, indicating a potential upside of 3.68%. Given Insulet's stronger consensus rating and higher probable upside, research analysts clearly believe Insulet is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	2 Sell rating(s)	4 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.71
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43

Summary

Insulet beats Henry Schein on 11 of the 16 factors compared between the two stocks.

How does Henry Schein compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

AMN Healthcare Services presently has a consensus target price of $29.00, indicating a potential downside of 11.80%. Henry Schein has a consensus target price of $88.62, indicating a potential upside of 3.68%. Given Henry Schein's stronger consensus rating and higher possible upside, analysts plainly believe Henry Schein is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43

Henry Schein has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.47	-$95.70M	-$0.87	N/A
Henry Schein	$13.18B	0.74	$398M	$3.31	25.82

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by company insiders. Comparatively, 0.9% of Henry Schein shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Henry Schein has a net margin of 2.95% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
Henry Schein	2.95%	15.44%	5.53%

AMN Healthcare Services has a beta of 0.41, suggesting that its stock price is 59% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

In the previous week, Henry Schein had 8 more articles in the media than AMN Healthcare Services. MarketBeat recorded 12 mentions for Henry Schein and 4 mentions for AMN Healthcare Services. Henry Schein's average media sentiment score of 1.32 beat AMN Healthcare Services' score of 0.04 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Henry Schein	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Henry Schein beats AMN Healthcare Services on 13 of the 16 factors compared between the two stocks.

Get Henry Schein News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HSIC vs. The Competition

Export

Metric	Henry Schein	MED/DENTAL Industry	Medical Sector	NASDAQ Exchange
Market Cap	$9.63B	$16.50B	$6.88B	$12.26B
Dividend Yield	N/A	1.33%	2.67%	9.79%
P/E Ratio	25.82	18.87	27.00	23.71
Price / Sales	0.74	2.13	492.77	76.09
Price / Cash	10.86	13.96	50.54	59.64
Price / Book	2.58	3.21	10.28	6.07
Net Income	$398M	$534.24M	$3.60B	$331.84M
7 Day Performance	-2.68%	-2.71%	-1.25%	-1.53%
1 Month Performance	2.13%	0.42%	-0.35%	-2.46%
1 Year Performance	19.61%	-3.81%	18.41%	13.66%

Henry Schein Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HSIC Henry Schein	3.7454 of 5 stars	$85.47 +1.1%	$88.62 +3.7%	+17.7%	$9.63B	$13.18B	25.82	25,000	News Coverage
COO Cooper Companies	3.2924 of 5 stars	$71.32 +0.9%	$81.85 +14.8%	-4.7%	$13.79B	$4.09B	60.44	15,000	News Coverage Positive News
IDXX IDEXX Laboratories	3.4346 of 5 stars	$564.21 +0.1%	$751.00 +33.1%	-1.0%	$44.46B	$4.30B	41.55	11,000	News Coverage Positive News
MMSI Merit Medical Systems	3.8715 of 5 stars	$73.26 -0.2%	$92.80 +26.7%	-11.8%	$4.38B	$1.52B	31.71	7,500	Positive News Upcoming Earnings Analyst Revision
PODD Insulet	4.6058 of 5 stars	$162.06 +0.5%	$235.25 +45.2%	-43.0%	$11.17B	$2.71B	37.69	5,400	Trending News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HSIC) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Henry Schein (HSIC) Competitors

HSIC vs. COO, IDXX, MMSI, PODD, and AMN

How does Henry Schein compare to Cooper Companies?

Summary

How does Henry Schein compare to IDEXX Laboratories?

Summary

How does Henry Schein compare to Merit Medical Systems?

Summary

How does Henry Schein compare to Insulet?

Summary

How does Henry Schein compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSIC vs. The Competition

Henry Schein Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Henry Schein (HSIC) Competitors

HSIC vs. COO, IDXX, MMSI, PODD, and AMN

How does Henry Schein compare to Cooper Companies?

Do insiders & institutionals believe in HSIC or COO?

Do analysts rate HSIC or COO?

Is HSIC or COO more profitable?

Which has higher earnings & valuation, HSIC or COO?

Which has more risk and volatility, HSIC or COO?

Does the media refer more to HSIC or COO?

Summary

How does Henry Schein compare to IDEXX Laboratories?

Which has more risk & volatility, HSIC or IDXX?

Does the media prefer HSIC or IDXX?

Do analysts rate HSIC or IDXX?

Do insiders and institutionals have more ownership in HSIC or IDXX?

Is HSIC or IDXX more profitable?

Which has stronger earnings & valuation, HSIC or IDXX?

Summary

How does Henry Schein compare to Merit Medical Systems?

Do analysts recommend MMSI or HSIC?

Which has preferable valuation & earnings, MMSI or HSIC?

Does the media favor MMSI or HSIC?

Do insiders & institutionals have more ownership in MMSI or HSIC?

Which has more risk and volatility, MMSI or HSIC?

Is MMSI or HSIC more profitable?

Summary

How does Henry Schein compare to Insulet?

Is PODD or HSIC more profitable?

Does the media refer more to PODD or HSIC?

Do institutionals and insiders have more ownership in PODD or HSIC?

Which has stronger earnings and valuation, PODD or HSIC?

Which has more volatility and risk, PODD or HSIC?

Do analysts recommend PODD or HSIC?

Summary

How does Henry Schein compare to AMN Healthcare Services?

Do analysts recommend AMN or HSIC?

Which has higher valuation and earnings, AMN or HSIC?

Do institutionals & insiders have more ownership in AMN or HSIC?

Is AMN or HSIC more profitable?

Which has more volatility & risk, AMN or HSIC?

Does the media refer more to AMN or HSIC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSIC vs. The Competition

Henry Schein Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools